HomeCONGRESS

CONGRESS

ACC 2022 | APOLLO

Lipoprotein a (Lp a) is an important risk factor for atherothrombosis and atherosclerotic cardiovascular disease, but it...

ACC 2022 – EDIT-CMD

Roughly 40% of patients receiving a coronary angiography for stable angina (angina episodes twice a week despite...

ACC 2022 – Complete Trial QoL: Complete Revascularization in STEMI

The COMPLETE study has shown complete revascularization in STEMI reduces cardiovascular mortality or new AMI, which generated...

ACC 2022 | VALOR-HCM: Mavacamten in Adults with Symptomatic Obstructive HCM Eligible for Septal Reduction Therapy

Roughly 50% of hypertrophic cardiomyopathies (HCM) are obstructive, and of this percentage, most of symptoms can be...

ACC 2022 – POISE-3: Tranexamic Acid, Bleeding and Cardiovascular Events in Non-Cardiac Surgeries

Tranexamic Acid is an antifibrinolytic which has been shown to reduce bleeding in orthopedic patients and cardiac...

ACC 2022

Here are the most important scientific articles of the ACC 2022 Congress. If you cannot view the articles,...

Rewatch our Webinar on Conquering Complex Coronary Lesions on our Youtube channel

Rewatch our Webinar on Conquering Complex Coronary Lesions on our Youtube channel. See it below! Conquering Complex Coronary Lesions

SOLACI’s Symposium at PCI Global Summit

More SOLACI activities before the end of the year! We invite you to join this scientific activity of...